Moore Capital Management’s Sanofi SNY Stock Holding History

Moore Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1M	Buy	329,779 +64,723	+24%	+$2.89M	0.21%	91
2026 Q1	$12.8M	Sell	265,056 -10,004	-4%	-$466K	0.26%	66
2025 Q4	$13.3M	Buy	275,060 +225,779	+458%	+$11.2M	0.19%	124
2025 Q3	$2.33M	Buy	+49,281	New	+$2.38M	0.03%	342

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Moore Capital Management's SNY Position: Q2 2026 in Review

Moore Capital Management increased its Sanofi (SNY) stake by 24% in Q2 2026, buying an estimated $2.89M and bringing the position to 329,779 shares worth $14.1M. The position accounts for 0.21% of the portfolio, ranked #91.

Moore Capital Management first reported a position in SNY in Q3 2025 and has held it in 4 quarters since. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Moore Capital Management held 329,779 shares of Sanofi worth $14.1M as of Q2 2026.
Moore Capital Management bought 64,723 Sanofi shares in Q2 2026, an estimated $2.89M.
Sanofi made up 0.21% of Moore Capital Management's portfolio in Q2 2026, its #91 holding.
Moore Capital Management first reported a position in Sanofi in Q3 2025 and has held it in 4 quarters since.
715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.